Distillations | Science History Institute

This episode is a co-production with Lost Women of Science. Agnes Pockels did pioneering work in surface science. Her invention, the Pockels Trough, became the basis for an instrument that helped Katherine Burr Blodgett and Irving Langmuir make discoveries in material science that quietly shape our everyday world. But the way we talk about Agnes's life and work often falls back on familiar tropes about women's domestic roles, assumptions about how science gets done, and what it looked like to do science as a woman in the 19th century. Agnes's story invites us to rethink how we define success for scientists. Is our definition too narrow? And what might we gain if we crack it open a bit wider? Credits Host: Alexis PedrickExecutive Producer: Mariel CarrProducer: Rigoberto Hernandez Additional Reporting: Sophia Levin Art Design: Lily Whear Fact-Checking: Alexandria Attia Sound Design: Ana Tuirán Guests Brigitte Van Tiggelen Brigitte Van Tiggelen is the Science History Institute's director of international affairs, working from the Institute's office in Paris. Trained as both a physicist and a historian, she is the coeditor of Women in Their Element: Selected Women's Contributions to the Periodic System (2019), a volume that brings together more than two decades of research and publication of the life and work of women in science. Donald L. Opitz Donald L. Opitz is a historian of science who teaches in the School of Continuing and Professional Studies and Department of History at DePaul University. He is writing a book that traces the international movement for the advancement of women in agriculture and horticulture from the mid-19th to mid-20th centuries. Petra Mishnik Petra Mischnick was a professor of food chemistry at Technische Universität Braunschweig, Germany. There she founded and ran the Agnes Pockels Student Lab to inspire young children, especially girls, to pursue science. Resource List Kohlstedt, Sally Gregory and Opitz, Don. "Agnes Pockels - Surface Chemist and 'Hausfrau'," The Changing Image of the Sciences. 2002. Pockels, Agnes. "On the Relative Contamination of the Water-Surface by Equal Quantities of Different Substances." Nature, 1892. Sella, Andrea. "Pockels' Trough." Chemistry World, 2015. Tiggelen, Brigitte Van. "Fräulein Agnes Pockels: The Shaping of a 'Forschende Hausfrau'," paper presented at the 24th International Congress of History of Science, Technology, and Medicine. Bergwik, Staffan; Opitz, Donald L.; Tiggelen, Brigitte Van. Domesticity in the Making of Modern Science. 2016. A full transcript is available on our website.

Alexis Pedrick joins Katie Hafner to bring you an episode from The Lost Women of Science Initiative, a non-profit educational organization dedicated to telling the forgotten or untold stories of remarkable female scientists and their groundbreaking work through history. The episode, which originally aired in October 2023, is about Flemmie Kittrell, the first Black woman to earn a PhD in Home Economics. In the early 1960s, Flemmie decided to see what would happen if you gave poor kids a boost early in life, in the form of a really great preschool. Every day for two years, parents would get free childcare, and their kids would get comprehensive care for body and mind—with plenty of nutritious food, fun activities, and hugs. What kind of difference would that make? And would it matter later on? Credits Host: Alexis Pedrick Executive Producer: Mariel Carr Producer: Rigoberto Hernandez Associate Producer: Sarah Kaplan Music by Blue Dot Sessions Resource List Flemmie Kittrell audio interviews, Black Women Oral History Project Interviews, 1976–1981, the Harvard Radcliffe Institute's Schlesinger Library Institute Kittrell, Flemmie, "The Negro Family as a Health Agency," The Journal of Negro Education, Vol. 18, No. 3, The Health Status and Health, 1949 Baure, Lauren, "Does Head Start Work?," The Brookings Institution, 2019 Horrocks, Allison, Good Will Ambassador with a Cookbook: Flemmie Kittrell and the International Politics of Home Economics, University of Connecticut, 2016 First report on Howard Preschool Experiment: Prelude to School: An Evaluation of an Inner-City Preschool Program, Children's Bureau (DREW), Washington, D.C. Social and Rehabilitation Service, 1968 ‍ Talbot, Margaret, " Did Home Economics Empower Women?," The New Yorker, 2021 Zigler, Edward, and Muenchow, Susan, Head Start: The Inside Story Of America's Most Successful Education Experiment, 1994.

Françoise Bayliss, a bioethicist who studies ethics of genome editing, and Kiran Musunuru, a cardiologist and CRISPR expert, discuss the 2018 gene-edited twin controversy. They explore CRISPR’s rise, technical flaws in the reported edits, ethical and consent failures, and the scientific community’s response. The conversation also touches on clinical successes and debates over oversight and regulation.

Surekha Davies, historian of science, art, and ideas who studies categories and the cultural history of monsters. She explains monsters as beings that blur boundaries. She talks about genes, viruses, and the microbiome complicating what it means to be human. She traces public fears about early genetic engineering and reframes monstrosity as uniqueness.

Robin Marantz, author and historian of reproductive science, traces IVF from 19th-century artificial insemination to the 1960s–70s race that produced the first test-tube baby. Short, vivid stories cover scientific struggles, dramatic conflicts between researchers, surprising patient experiences, and how early choices set the stage for later debates about cloning and gene editing.

When Rebekah and Evan Lockard's daughter, Naomi, was diagnosed with a devastating ultra-rare genetic disease, they didn't know where to turn. Then they found Terry Pirovolakis, an IT professional who had made a gene therapy for his son with the same disease. But the process of getting Naomi treated has been an uphill battle, full of financial and logistical obstacles. The Lockard's story flips the question we've been asking all season on its head. Instead of wondering, "if we could do something, should we," we're now asking, "if we can do something that helps patients, should we do it at any cost?" And this question isn't for scientists or researchers, it's for the rest of us. Credits Host: Alexis Pedrick Executive Producer: Mariel Carr Producer: Rigoberto Hernandez Associate Producer: Sarah Kaplan Audio Engineer: Samia Bouzid Music by Blue Dot Sessions Resource List Mast, Jason. "A dad built a gene therapy for his son. Can he save other kids, too?" STAT News. Elpida Therapeutics. "Battling SPG50 and changing the world." August 17, 2022. The Jackson Laboratory. Brent, Jonathan R. and Deng, Han-Xiang. "Paving a way to treat spastic paraplegia 50." "AAV gene therapy for hereditary spastic paraplegia type 50: a phase 1 trial in a single patient." June 28, 2004. "Colorado family pushes for more funding, awareness around rare neurological disorder." August 12, 2024. CBS News Colorado. Naomi's Corner.

Gene therapy is based on a simple-sounding, yet deceptively complicated premise: adding or replacing faulty genes to fix medical problems. A compelling idea that came out of breakthroughs in DNA research, the field grew lightning fast. But the death of teenager Jesse Gelsinger after a gene therapy clinical trial left the public and scientists questioning the field's promise. Why did researchers push ahead with clinical trials despite gene therapy still being in its infancy? What does the Jesse Gelsinger story tell us about the personal risk behind medical breakthroughs? Credits Host: Alexis Pedrick Executive Producer: Mariel Carr Producer: Rigoberto Hernandez Associate Producer: Sarah Kaplan Audio Engineer: Samia Bouzid Music by Blue Dot Sessions Resource List American Experience: The Boy in the Bubble. PBS. Begley, Sharon. "Out of Prison, the 'Father of Gene Therapy' Faces a Harsh Reality: a Tarnished Legacy and an Ankle Monitor." STAT News, July 23, 2018. Cobb, Matthew. As Gods: A Moral History of the Genetic Age. New York: Basic Books, 2022. "C‑SPAN: Paul Gelsinger." C‑SPAN. Gelsinger, Paul L. "Jesse's Intent." Circare. ABC Evening News. Vanderbilt Television News Archive, December 8, 1999. CBS Evening News. Vanderbilt Television News Archive, May 28, 1999. NBC Nightly News Broadcast. Vanderbilt Television News Archive, December 8, 1999. "Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy." Georgetown University Library. Rinde, Meir. "The Death of Jesse Gelsinger, 20 Years Later." Science History Institute, June 4, 2019. Stolberg, Sheryl Gay. "The Biotech Death of Jesse Gelsinger." New York Times Magazine, November 28, 1999. "Teen Dies Undergoing Experimental Gene Therapy." Washington Post, September 29, 1999. "The Glimmering Promise of Gene Therapy." MIT Technology Review, November 1, 2006. The NewsHour with Jim Lehrer, 1999-12-08. NewsHour Productions. American Archive of Public Broadcasting (GBH and the Library of Congress), Boston, MA and Washington, DC. Wilson, James . "Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency."

Producer Mariel Carr talks to historian of science and former Science History Institute fellow, Luis Campos, about his article "Strains of Andromeda: The Cosmic Potential Hazards of Genetic Engineering." He shares how Michael Crichton's first novel and the subsequent film influenced the conversation and controversy around recombinant DNA research in the 1970s. Credits Host: Alexis Pedrick Executive Producer: Mariel Carr Producer: Rigoberto Hernandez Associate Producer: Sarah Kaplan Audio Engineer: Samia Bouzid Music by Blue Dot Sessions Resource List The Andromeda Strain. IMDb. Campos, Luis A. "Strains of Andromeda: The Cosmic Potential Hazards of Genetic Engineering."

Jonathan King, Professor Emeritus of Molecular Biology at MIT, offers first-person recollections of the 1976 Cambridge recombinant DNA hearings. He recalls televised city council drama, a populist mayor challenging scientific authority, debates over who should decide research rules, and how early safety concerns and local review shaped biotech’s future.

Michael Rogers, journalist who covered the 1975 Asilomar meeting for Rolling Stone, shares first-person recollections. He recounts the tense media interest and who packed the conference. He describes the debates over safety fixes, containment levels, legal threats, and how scientists weighed publicity, patents, and public accountability.